Business
USOP Names Johnson & Johnson Its Official Vendor for Total Joint Products
U.S. Orthopaedic Partners (USOP) announced a strategic agreement today with Johnson & Johnson to make the medtech solutions giant its official vendor for total joint products. The agreement is projected to deliver immediate, meaningful value for the platform as it continues to elevate clinical quality and patient outcomes.
About this update from Johnson & Johnson
[{"type":"text","content":"ALPHARETTA, Ga., Oct. 2, 2025 /PRNewswire/ -- U.S. Orthopaedic Partners (USOP) announced a strategic agreement today with Johnson & Johnson to make the medtech solutions giant its official vendor for total joint products. The agreement is projected to deliver immediate, meaningful value for the platform as it continues to elevate clinical quality and patient outcomes.","length":374,"tagName":"p"},{"type":"image","alt":"U.S. Orthopaedic Partners is the nation’s leading orthopedic management services organization, supporting a network of 10 premier orthopedic practices across the Southeast. By focusing on strategic growth, operational excellence, and physician alignment, USOP empowers practices and physicians to thrive in an evolving healthcare landscape.\r\n\r\nFor more information, visit us-orthopartners.com. (PRNewsfoto/U.S. Orthopaedic Partners)","displaySize":"","headline":null,"caption":"U.S. Orthopaedic Partners is the nation’s leading orthopedic management services organization, supporting a network of 10 premier orthopedic practices across the Southeast. By focusing on strategic growth, operational excellence, and physician alignment, USOP empowers practices and physicians to thrive in an evolving healthcare landscape. For more information, visit us-orthopartners.com. (PRNewsfoto/U.S. Orthopaedic Partners)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":139,"url":"https://media.zenfs.com/en/prnewswire.com/d87aa50ae056ac9b24564eafb79bf305"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/OVmOfGix3Rs9LfS7cyolcg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTI0NTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/d87aa50ae056ac9b24564eafb79bf305","width":400,"height":139}},"href":"https://mma.prnewswire.com/media/2652179/USOP_Color_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Clinical Quality Was the Overriding CriterionFrom day one, clinical performance and long-term outcomes were the non-negotiable drivers of this decision. USOP's Physician Board led the evaluation, requiring head-to-head clinical reviews and outcomes benchmarking, and every selected product met rigorous performance and durability standards before receiving final sign-off.","length":377,"tagName":"p"},{"type":"text","content":""This was first and foremost about clinical qual...